Oncogenetics

Abstract

Oncogenetic is primarily a predictive and preventive science in the field of genetics that focuses mainly on hereditary cancers. It’s a fascinating branch of genetics that delves into the relationship between genes and cancer. It explores how genetic variations can influence the risk of developing cancer, as well as how this information can be utilized for cancer prevention, diagnosis, and personalized treatment. At the core of oncogenetics is the identification of specific genes, known as oncogenes, which play crucial roles in the cellular transformation process leading to cancer. These oncogenes can be activated by various genetic mutations, whether inherited or acquired throughout life. Similarly, certain genetic variations, known as cancer susceptibility variants, may increase predisposition to specific types of cancer. Understanding oncogenetics also involves studying the complex interplay between genes and the environment, as external factors such as exposure to carcinogens or lifestyle choices can interact with genetic predisposition to influence cancer risk. The advent of high-throughput sequencing technologies has revolutionized the field of oncogenetics, enabling in-depth analysis of the genomes of cancer patients. This has opened new avenues for personalized medicine, where genetic information can guide the selection of the most effective and individualized treatments, as well as the implementation of early screening programs for individuals at risk. In summary, oncogenetics is an essential discipline in the fight against cancer, offering promising insights for better understanding the disease and the development of more targeted and effective prevention and treatment strategies. A significant proportion of cancers are linked to the presence of a hereditary genetic alteration, meaning that a gene anomaly has been present since birth and can therefore be passed on to offspring. This module aims to shed light on the study of the genome of human tumor cells, which has revealed a much larger number of genetic and epigenetic alterations than previously anticipated. These changes occur in various molecular mechanisms, thus controlling the proliferation and survival of abnormal cells during tumor progression.